Dr. McNulty is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Health Park Dr
Suite 220, Rex Hematology Oncology Associates Of Garner
Garner, NC 27529Phone+1 919-250-5955Fax+1 919-250-5954
Education & Training
Brown UniversityFellowship, Hematology and Medical Oncology, 2006 - 2009
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2003 - 2006
University of Massachusetts Medical SchoolClass of 2003
Certifications & Licensure
NC State Medical License 2013 - 2024
MA State Medical License 2005 - 2015
RI State Medical License 2006 - 2010- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 15 citationsReal-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples.Scott A. Tomlins, Daniel H. Hovelson, Jennifer Marie Suga, Daniel M. Anderson, Han A. Koh
JCO Precision Oncology. 2021-08-19 - 34 citationsLapatinib/gemcitabine and lapatinib/gemcitabine/oxaliplatin: a phase I study for advanced pancreaticobiliary cancer.Howard Safran, Thomas J. Miner, Murray B. Resnick, Thomas A. DiPetrillo, Brendan McNulty
American Journal of Clinical Oncology. 2008-04-01 - 72 citationsNeoadjuvant Bevacizumab, Oxaliplatin, 5-Fluorouracil, and Radiation for Rectal CancerT. Dipetrillo, Victor E. Pricolo, Jorge A. Lagares-Garcia, Matt Vrees, Adam Klipfel
International Journal of Radiation Oncology, Biology, Physics. 2012-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
